Enough experimenting! The KIT spinoff GoSilico enables the biopharmaceuticals branch to introduce the computer-supported development of manufacturing processes for new agents.
The way from the discovery of a promising agent to its authorisation is tedious. It involves countless experiments that not only cause high costs but also require a considerable amount of perseverance. “It can take up to ten years for a drug to enter the market,” says Dr Thiemo Huuk. This is a shortcoming that he tends to address together with his co-founders Prof Dr Jürgen Hubbuch, Dr Teresa Beck and Dr Tobias Hahn.
The founders of GoSilico (left to right): Dr. Thiemo Huuk, Dr. Tobias Hahn and Dr. Teresa Beck (Source: Foto Fabry)
On 11/12/2015, the CyberChampions Award was awarded as part of the ShareBW Congress. The prize was offered to founders and young businesses from the extended TechnologieRegion Karlsruhe (Karlsruhe TechnologyRegion) in the categories “Best Concept” and “NewComer” as well as a special prize for “Innovation.” As early as October, 29 applicant teams pitched in order to be selected for one of the coveted spots in the finals. A 17-person jury, including former prize recipients as well as representatives from industry and economy, evaluated the submissions. The decisive factors for a spot in the finals were specific know-how about markets and customers, a clear positioning, and a smart strategy. Ten startup teams with roots at the KIT were selected among the 11 finalists. Continue reading